HIV+ Pregnant Women and Antiretroviral Treatment: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
==Baltimore Classification== | ==Baltimore Classification== | ||
<br> | <br> | ||
==Higher order categories== | ==Higher order categories== | ||
<br> | <br> | ||
==Description and Significance== | ==Description and Significance== | ||
Line 20: | Line 18: | ||
[[Image:SickBird.jpeg|thumb|300px|left| <i>Gallus gallus domesticus</i> showing obvious signs of late-stage CAV infection. [http://partnersah.vet.cornell.edu/avian-atlas/search/disease/504].]] | [[Image:SickBird.jpeg|thumb|300px|left| <i>Gallus gallus domesticus</i> showing obvious signs of late-stage CAV infection. [http://partnersah.vet.cornell.edu/avian-atlas/search/disease/504].]] | ||
<br> | <br> | ||
==Genome Structure== | ==Genome Structure== | ||
<br> | <br> | ||
==Virion Structure of Chicken Anemia Virus== | ==Virion Structure of Chicken Anemia Virus== | ||
<br> | <br> | ||
==Reproductive Cycle of CAV in a Host Cell== | ==Reproductive Cycle of CAV in a Host Cell== | ||
<br> | <br> | ||
==Viral Ecology & Pathology== | ==Viral Ecology & Pathology== | ||
[[Image:Adair.jpeg|thumb|300px|right| Immunopathogenesis of Chicken Anemia Virus. Hemocytoblasts in the bone marrow, and T cell progenitors in the thymus are the CAV's key targets. [http://www.sciencedirect.com/science/article/pii/S0145305X99000762#].]] | [[Image:Adair.jpeg|thumb|300px|right| Immunopathogenesis of Chicken Anemia Virus. Hemocytoblasts in the bone marrow, and T cell progenitors in the thymus are the CAV's key targets. [http://www.sciencedirect.com/science/article/pii/S0145305X99000762#].]] | ||
<br> | <br> | ||
==References== | ==References== | ||
Line 57: | Line 39: | ||
[1] Barton-Knott, Sophie. 2011. Nearly 50% of People Who are Eligible for Antiretroviral Therapy Now Have Access to Lifesaving Treatment. UNAIDS press release. http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/november/20111121wad2011report/. <br><br> | [1] Barton-Knott, Sophie. 2011. Nearly 50% of People Who are Eligible for Antiretroviral Therapy Now Have Access to Lifesaving Treatment. UNAIDS press release. http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/november/20111121wad2011report/. <br><br> | ||
[2] Centers for Disease Control and Prevention. 2010. HIV Transmission. http://www.cdc.gov/hiv/resources/qa/transmission.htm. <br><br> | [2] Centers for Disease Control and Prevention. 2010. HIV Transmission. http://www.cdc.gov/hiv/resources/qa/transmission.htm. <br><br> | ||
[3] Foster, C., H. Lyall, B, Olmscheid, G. Pearce, S. Zhang and D. Gibb. 2009. Tenofovir Disproxil Fumarate in Pregnancy and Prevention of Mother-to-Child-Transmission of HIV-1: Is it Time to Move on From Zidovudine? HIV Medicine. 10: 397-406. | [3] Foster, C., H. Lyall, B, Olmscheid, G. Pearce, S. Zhang and D. Gibb. 2009. Tenofovir Disproxil Fumarate in Pregnancy and Prevention of Mother-to-Child-Transmission of HIV-1: Is it Time to Move on From Zidovudine? HIV Medicine. 10: 397-406. <br><br> | ||
Revision as of 03:09, 9 November 2012
A Viral Biorealm page on the family HIV+ Pregnant Women and Antiretroviral Treatment
The human immunodeficiency virus (HIV) has been a global epidemic for over 30 years. Approximately 35 million worldwide are infected with HIV [1]. If untreated, HIV progresses to acquired immunodeficiency syndrome (AIDS), which is almost surely fatal. HIV is transmitted by multiple methods; sexually, via contact with contaminated blood, and from mother to child in utero are the primary methods [2]. Mother to child transmission (MTCT) has been a topic of great research and, by following guidelines, it is now nearly guaranteed that an HIV+ mother can have an HIV- child. In well-resourced countries the rate of MTCT is <1% [3].
Baltimore Classification
Higher order categories
Description and Significance
Genome Structure
Virion Structure of Chicken Anemia Virus
Reproductive Cycle of CAV in a Host Cell
Viral Ecology & Pathology
References
[1] Barton-Knott, Sophie. 2011. Nearly 50% of People Who are Eligible for Antiretroviral Therapy Now Have Access to Lifesaving Treatment. UNAIDS press release. http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/november/20111121wad2011report/.
[2] Centers for Disease Control and Prevention. 2010. HIV Transmission. http://www.cdc.gov/hiv/resources/qa/transmission.htm.
[3] Foster, C., H. Lyall, B, Olmscheid, G. Pearce, S. Zhang and D. Gibb. 2009. Tenofovir Disproxil Fumarate in Pregnancy and Prevention of Mother-to-Child-Transmission of HIV-1: Is it Time to Move on From Zidovudine? HIV Medicine. 10: 397-406.
Page authored by Ellen Gaglione for BIOL 375 Virology, September 2010